| abstract |
The invention relates, 20 (S) - ginsenoside Rg 3 and 20 (S) - ginsenoside Rh mechanism of action for 2 neurons and the it has investigated its efficacy in detail, nerve compositions of the present invention is excellent A composition having a glutamate-mediated neurotoxicity inhibitory effect that can be used for the treatment of brain diseases such as brain trauma, stroke, cerebral ischemia, gout, epilepsy, Alzheimer's disease or Huntington's disease because it has a toxicity inhibitory or neuroprotective effect. Offer. A 20 (S) - ginsenoside Rg 3, 20 (S) - ginsenoside Rh 2, and 20 (S) - ginsenoside Rg 3 and 20 (S) - mixture glutamate-mediated neurotoxicity inhibiting composition comprising the ginsenoside Rh 2 object. [Selection diagram] None |